Cargando…

Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding

BACKGROUND: SARS-CoV-2 nucleocapsid antigen can be detected in plasma, but little is known about its performance as a diagnostic test for acute SARS-CoV-2 infection or infectious viral shedding among nonhospitalized individuals. METHODS: We used data generated from anterior nasal and blood samples c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathur, Sujata, Davidson, Michelle C, Anglin, Khamal, Lu, Scott, Goldberg, Sarah A, Garcia-Knight, Miguel, Tassetto, Michel, Zhang, Amethyst, Romero, Mariela, Pineda-Ramirez, Jesus, Diaz-Sanchez, Ruth, Rugart, Paulina, Chen, Jessica Y, Donohue, Kevin, Shak, Joshua R, Chenna, Ahmed, Winslow, John W, Petropoulos, Christos J, Yee, Brandon C, Lambert, Jeremy, Glidden, David V, Rutherford, George W, Deeks, Steven G, Peluso, Michael J, Andino, Raul, Martin, Jeffrey N, Kelly, J Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620332/
https://www.ncbi.nlm.nih.gov/pubmed/36381627
http://dx.doi.org/10.1093/ofid/ofac563
_version_ 1784821324552601600
author Mathur, Sujata
Davidson, Michelle C
Anglin, Khamal
Lu, Scott
Goldberg, Sarah A
Garcia-Knight, Miguel
Tassetto, Michel
Zhang, Amethyst
Romero, Mariela
Pineda-Ramirez, Jesus
Diaz-Sanchez, Ruth
Rugart, Paulina
Chen, Jessica Y
Donohue, Kevin
Shak, Joshua R
Chenna, Ahmed
Winslow, John W
Petropoulos, Christos J
Yee, Brandon C
Lambert, Jeremy
Glidden, David V
Rutherford, George W
Deeks, Steven G
Peluso, Michael J
Andino, Raul
Martin, Jeffrey N
Kelly, J Daniel
author_facet Mathur, Sujata
Davidson, Michelle C
Anglin, Khamal
Lu, Scott
Goldberg, Sarah A
Garcia-Knight, Miguel
Tassetto, Michel
Zhang, Amethyst
Romero, Mariela
Pineda-Ramirez, Jesus
Diaz-Sanchez, Ruth
Rugart, Paulina
Chen, Jessica Y
Donohue, Kevin
Shak, Joshua R
Chenna, Ahmed
Winslow, John W
Petropoulos, Christos J
Yee, Brandon C
Lambert, Jeremy
Glidden, David V
Rutherford, George W
Deeks, Steven G
Peluso, Michael J
Andino, Raul
Martin, Jeffrey N
Kelly, J Daniel
author_sort Mathur, Sujata
collection PubMed
description BACKGROUND: SARS-CoV-2 nucleocapsid antigen can be detected in plasma, but little is known about its performance as a diagnostic test for acute SARS-CoV-2 infection or infectious viral shedding among nonhospitalized individuals. METHODS: We used data generated from anterior nasal and blood samples collected in a longitudinal household cohort of SARS-CoV-2 cases and contacts. Participants were classified as true positives if polymerase chain reaction (PCR) positive for SARS-CoV-2 and as true negatives if PCR negative and seronegative. Infectious viral shedding was determined by the cytopathic effect from viral culture. Stratified by 7 days after symptom onset, we constructed receiver operating characteristic (ROC) curves to describe optimized accuracy (Youden index), optimized sensitivity, and specificity. RESULTS: Of 80 participants, 58 (73%) were true positives while 22 (27%) were true negatives. Using the manufacturer's cutoff of 1.25 pg/mL for evaluating infection, sensitivity was higher from 0 to 7 days (77.6% [95% confidence interval {CI}, 64%–88.2%]) than from 8 to 14 days (43.2% [95% CI, 31.1%–54.5%]) after symptom onset; specificity was unchanged at 100% (95% CI, 88.1%–100%). This test had higher sensitivity (100% [95% CI, 88.4%–100%]) and lower specificity (65% [95% CI, 40.8%–84.6%]) for infectious viral shedding as compared with infection, particularly within the first week of symptom onset. Although the presence of N-antigen correlated with infectious viral shedding (r = 0.63; P < .01), sensitivity still declined over time. Additional cutoffs from ROC curves were identified to optimize sensitivity and specificity. CONCLUSIONS: We found that this SARS-CoV-2 N-antigen test was highly sensitive for detecting early but not late infectious viral shedding, making it a viable screening test for community-dwelling individuals to inform isolation practices.
format Online
Article
Text
id pubmed-9620332
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96203322022-11-04 Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding Mathur, Sujata Davidson, Michelle C Anglin, Khamal Lu, Scott Goldberg, Sarah A Garcia-Knight, Miguel Tassetto, Michel Zhang, Amethyst Romero, Mariela Pineda-Ramirez, Jesus Diaz-Sanchez, Ruth Rugart, Paulina Chen, Jessica Y Donohue, Kevin Shak, Joshua R Chenna, Ahmed Winslow, John W Petropoulos, Christos J Yee, Brandon C Lambert, Jeremy Glidden, David V Rutherford, George W Deeks, Steven G Peluso, Michael J Andino, Raul Martin, Jeffrey N Kelly, J Daniel Open Forum Infect Dis Major Article BACKGROUND: SARS-CoV-2 nucleocapsid antigen can be detected in plasma, but little is known about its performance as a diagnostic test for acute SARS-CoV-2 infection or infectious viral shedding among nonhospitalized individuals. METHODS: We used data generated from anterior nasal and blood samples collected in a longitudinal household cohort of SARS-CoV-2 cases and contacts. Participants were classified as true positives if polymerase chain reaction (PCR) positive for SARS-CoV-2 and as true negatives if PCR negative and seronegative. Infectious viral shedding was determined by the cytopathic effect from viral culture. Stratified by 7 days after symptom onset, we constructed receiver operating characteristic (ROC) curves to describe optimized accuracy (Youden index), optimized sensitivity, and specificity. RESULTS: Of 80 participants, 58 (73%) were true positives while 22 (27%) were true negatives. Using the manufacturer's cutoff of 1.25 pg/mL for evaluating infection, sensitivity was higher from 0 to 7 days (77.6% [95% confidence interval {CI}, 64%–88.2%]) than from 8 to 14 days (43.2% [95% CI, 31.1%–54.5%]) after symptom onset; specificity was unchanged at 100% (95% CI, 88.1%–100%). This test had higher sensitivity (100% [95% CI, 88.4%–100%]) and lower specificity (65% [95% CI, 40.8%–84.6%]) for infectious viral shedding as compared with infection, particularly within the first week of symptom onset. Although the presence of N-antigen correlated with infectious viral shedding (r = 0.63; P < .01), sensitivity still declined over time. Additional cutoffs from ROC curves were identified to optimize sensitivity and specificity. CONCLUSIONS: We found that this SARS-CoV-2 N-antigen test was highly sensitive for detecting early but not late infectious viral shedding, making it a viable screening test for community-dwelling individuals to inform isolation practices. Oxford University Press 2022-10-22 /pmc/articles/PMC9620332/ /pubmed/36381627 http://dx.doi.org/10.1093/ofid/ofac563 Text en Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.
spellingShingle Major Article
Mathur, Sujata
Davidson, Michelle C
Anglin, Khamal
Lu, Scott
Goldberg, Sarah A
Garcia-Knight, Miguel
Tassetto, Michel
Zhang, Amethyst
Romero, Mariela
Pineda-Ramirez, Jesus
Diaz-Sanchez, Ruth
Rugart, Paulina
Chen, Jessica Y
Donohue, Kevin
Shak, Joshua R
Chenna, Ahmed
Winslow, John W
Petropoulos, Christos J
Yee, Brandon C
Lambert, Jeremy
Glidden, David V
Rutherford, George W
Deeks, Steven G
Peluso, Michael J
Andino, Raul
Martin, Jeffrey N
Kelly, J Daniel
Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding
title Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding
title_full Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding
title_fullStr Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding
title_full_unstemmed Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding
title_short Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding
title_sort evaluation of severe acute respiratory syndrome coronavirus 2 nucleocapsid antigen in the blood as a diagnostic test for infection and infectious viral shedding
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620332/
https://www.ncbi.nlm.nih.gov/pubmed/36381627
http://dx.doi.org/10.1093/ofid/ofac563
work_keys_str_mv AT mathursujata evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT davidsonmichellec evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT anglinkhamal evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT luscott evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT goldbergsaraha evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT garciaknightmiguel evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT tassettomichel evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT zhangamethyst evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT romeromariela evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT pinedaramirezjesus evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT diazsanchezruth evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT rugartpaulina evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT chenjessicay evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT donohuekevin evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT shakjoshuar evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT chennaahmed evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT winslowjohnw evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT petropouloschristosj evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT yeebrandonc evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT lambertjeremy evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT gliddendavidv evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT rutherfordgeorgew evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT deekssteveng evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT pelusomichaelj evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT andinoraul evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT martinjeffreyn evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding
AT kellyjdaniel evaluationofsevereacuterespiratorysyndromecoronavirus2nucleocapsidantigeninthebloodasadiagnostictestforinfectionandinfectiousviralshedding